WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003053344) SUBSTITUTED 2-METHYL-BENZIMIDAZOLE RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/053344    International Application No.:    PCT/US2002/039220
Publication Date: 03.07.2003 International Filing Date: 06.12.2002
Chapter 2 Demand Filed:    17.06.2003    
IPC:
C07D 235/26 (2006.01), C07D 401/06 (2006.01), C07D 403/06 (2006.01), C07D 413/14 (2006.01), C07D 471/04 (2006.01), C07D 513/04 (2006.01)
Applicants: BRISTOL-MYERS SQUIBB COMPANY [US/US]; P.O. Box 4000, Route 206 and Provinceline Road, Princeton, NJ 08543-4000 (US)
Inventors: YU, Kuo-Long; (US).
WANG, Xiangdong; (US).
SUN, Yaxiong; (US).
CIANCI, Christopher; (US).
THURING, Jan, Willem; (BE).
COMBRINK, Keith; (US).
MEANWELL, Nicholas; (US).
ZHANG, Yi; (US).
CIVIELLO, Rita, L.; (US)
Agent: DUBOFF, Samuel; Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543-4000 (US)
Priority Data:
60/339,025 10.12.2001 US
Title (EN) SUBSTITUTED 2-METHYL-BENZIMIDAZOLE RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS
(FR) 2-METHYL-BENZIMIDAZOLE SUBSTITUES EN TANT QU'AGENTS ANTIVIRAUX DU VIRUS RESPIRATOIRE SYNCYTIAL
Abstract: front page image
(EN)The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.
(FR)L'invention concerne des composés antiviraux, leurs procédés de préparation, leurs compositions et leur utilisation dans le traitement d'infections virales. Elle concerne plus particulièrement des dérivés 2-méthylbenzimidazole substitués, destinés au traitement de l'infection par le virus respiratoire syncytial.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)